Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease in the world, with a global prevalence of 25%. MASLD has an estimated prevalence of 34% in the United ...
Patients with type 2 diabetes mellitus (T2DM) have a significantly higher risk of cardiovascular disease (CVD) compared to the general population. Accurately predicting this risk is crucial for ...